Keymed Biosciences Inc. Stock
Stocks
2162
KYG5252B1023
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Hong Kong S.E.
14:37:44 13/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 69.05 HKD | -2.75% |
|
-0.51% | +29.00% |
| Market Cap | 17.8B 20.92B 2.67B 2.41B 2.23B 2.01B 3.8B 251B 3.92B 26.71B 10.62B 134B 10.01B 9.79B 427B | P/E 2026 * |
22.5x | P/E 2027 * | 411x |
|---|---|---|---|---|---|
| Enterprise Value | 16.9B 19.86B 2.53B 2.29B 2.11B 1.91B 3.61B 238B 3.72B 25.37B 10.08B 127B 9.5B 9.3B 405B | EV / Sales 2026 * |
10.4x | EV / Sales 2027 * | 7.59x |
| Free-Float |
74.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2162 | Delayed | |
Tradegate
| 64Z | Real-time | |
|
Deutsche Boerse AG
| 64Z | Delayed |
| 1 day | -2.89% | ||
| 1 week | -0.51% | ||
| Current month | +2.83% | ||
| 1 month | -12.00% | ||
| 3 months | -12.89% | ||
| 6 months | -2.54% | ||
| Current year | +29.00% |
| 1 week | 68.5 |  | 75.65 |
| 1 month | 62.45 | | 89.45 |
| Current year | 44.66 | | 89.75 |
| 1 year | 44.66 | | 89.75 |
| 3 years | 26.6 | | 89.75 |
| 5 years | 16.9 | | 89.75 |
| 10 years | 16.9 | | 89.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bo Chen
CEO | Chief Executive Officer | 52 | 23/04/2018 |
Changyu Wang
PRN | Corporate Officer/Principal | 61 | 03/03/2021 |
Pak Yu Tam
SEC | Corporate Secretary | - | 29/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Bo Chen
CHM | Chairman | 52 | 23/04/2018 |
Changyu Wang
BRD | Director/Board Member | 61 | 03/03/2021 |
Gang Xu
BRD | Director/Board Member | 52 | 21/06/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 13/6/25 | Moonshot Holdings Ltd.
| Other | Company | 21,600,000 | 7.7216% | |
| 11/6/25 | Moonshot Holdings Ltd.
| Other | Company | 18,800,000 | 6.7206% | |
| 15/9/23 | Moonshot Holdings Ltd.
| Other | Company | 114,500 | 0.0409% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.75% | -0.51% | +15.30% | +32.60% | 2.67B | |
| +1.10% | -2.67% | +62.79% | +70.47% | 68.45B | |
| +1.28% | +8.71% | +13.96% | +95.16% | 61.31B | |
| +0.36% | -0.95% | +20.09% | +99.04% | 55.73B | |
| -0.96% | +7.41% | +10.20% | +108.91% | 47.51B | |
| -1.25% | +2.35% | +22.74% | +38.34% | 44.68B | |
| -2.41% | -0.73% | +167.89% | +794.72% | 38.14B | |
| +1.21% | -2.56% | +20.27% | +52.81% | 35.85B | |
| -0.87% | -2.89% | +79.60% | +63.96% | 33.05B | |
| -2.22% | +8.56% | -39.26% | +397.14% | 25.9B | |
| Average | -0.67% | +2.52% | +37.36% | +175.31% | 41B | |
| Weighted average by Cap. | -0.17% | +2.83% | +40.07% | +163.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.63B 1.92B 244M 221M 204M 184M 348M 22.95B 359M 2.45B 972M 12.27B 916M 897M 39.06B | 2.25B 2.65B 337M 305M 281M 255M 481M 31.7B 495M 3.38B 1.34B 16.95B 1.27B 1.24B 53.94B |
| Net income | 680M 799M 102M 92.12M 85.04M 76.97M 145M 9.58B 150M 1.02B 406M 5.12B 382M 374M 16.3B | 16.85M 19.8M 2.52M 2.28M 2.11M 1.91M 3.6M 237M 3.71M 25.28M 10.05M 127M 9.47M 9.27M 404M |
| Net Debt | -897M -1.05B -134M -121M -112M -101M -192M -12.63B -197M -1.35B -535M -6.75B -504M -493M -21.49B | -717M -843M -107M -97.14M -89.66M -81.16M -153M -10.1B -158M -1.08B -428M -5.4B -403M -395M -17.18B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/11/26 | HK$69.05 | -2.75% | 1,031,003 |
| 12/11/26 | HK$71.00 | -0.35% | 1,180,000 |
| 11/11/26 | HK$71.25 | -1.72% | 1,322,200 |
| 10/11/26 | HK$72.50 | -0.48% | 940,700 |
| 09/11/26 | HK$72.85 | +5.12% | 2,695,893 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2162 Stock
Select your edition
All financial news and data tailored to specific country editions
